Group 1: Financial Performance - The company achieved a revenue of ¥394,229,848.87 in the first three quarters of 2024, representing a 15.78% increase compared to the same period last year [2] - The third quarter was impacted by a decline in sales prices of toluene oxidation products and increased operational costs due to the trial production of the tetrahydrofuran project [2] Group 2: Product Applications - Toluene oxidation products, derived from toluene, include benzyl alcohol, benzaldehyde, and benzoic acid, which are essential raw materials in the production of industrial chemicals, pharmaceuticals, pesticides, and fragrances [3] - Benzyl alcohol is widely used in electronic encapsulation, insulation paints, and as a solvent in various industries [3] Group 3: Investment Projects - The company's fundraising projects began trial production in the third quarter of this year, with the tetrahydrofuran project successfully achieving product sales [4] - The fundraising project facilities are still in the debugging and testing phase and have not yet been classified as fixed assets [4] Group 4: Competitive Advantages - The fundraising project is located in the Ulanqab High-tech Industrial Development Zone, surrounded by a cluster of BDO and PVC industries, enhancing the company's competitive edge and resource availability [5]

证券代码：832471 证券简称：美邦科技 公告编号：2024-081 河北美邦工程科技股份有限公司 董事会 2024 年 11 月 4 日 河北美邦工程科技股份有限公司（以下简称"公司"）董事会沉痛公告，公 司收到实际控制人之一刘东先生家属通知，刘东先生因病医治无效，于近日不幸 逝世。 刘东先生为公司实际控制人之一，为公司的发展做出了重大贡献，公司董事 会向刘东先生致以崇高的敬意和衷心的感谢，并向其家属表示深切慰问。 刘东先生目前持有公司股份 2,819,000 股，占公司股份总额的 3.39%。刘东 先生所持有的公司股份将根据相关法律法规办理股份继承手续，后续相关事宜公 司将依据相关法律法规的要求履行信息披露义务。 刘东先生未担任公司董事、监事或高级管理人员。刘东先生的逝世不会对公 司生产经营造成影响。公司董事会、监事会及高级管理人员正常履职，公司生产 经营业务正常进行。 河北美邦工程科技股份有限公司 关于公司实际控制人之一刘东先生逝世的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 ...

Group 1: Financial Performance - The company achieved a revenue of ¥394,229,848.87 in the first three quarters of 2024, representing a 15.78% increase compared to the same period last year [2] - The third quarter was impacted by a decline in sales prices of toluene oxidation products and increased operational costs due to the trial production of the tetrahydrofuran project [2] Group 2: Product Applications - Toluene oxidation products are key raw materials for industrial chemicals, pharmaceuticals, pesticides, and fragrances, including benzyl alcohol, benzaldehyde, and benzoic acid [3] - Benzyl alcohol is widely used in electronic encapsulation, insulation paints, and as a solvent in various industries [3] Group 3: Investment Projects - The company's fundraising projects began trial production in the third quarter of this year, with successful product sales from the tetrahydrofuran project [4] - The fundraising project facilities are still in the debugging and testing phase and have not yet been classified as fixed assets [4] Group 4: Competitive Advantages - The fundraising project is located in a high-tech industrial park in Wuhai, Inner Mongolia, near a cluster of BDO and PVC industries, providing significant competitive advantages and resource conditions [5]

Investment Rating - The investment rating for the company is "Accumulate" with a downward adjustment [5]. Core Views - The company has shown revenue and profit growth in the first three quarters of 2024, but experienced a decline in Q3 due to high base effects from Q2 [2]. - The company is a leader in the green chemical industry, with ongoing projects entering trial production phases [5]. - The stock repurchase plan is progressing well, with over half of the planned buyback completed [3]. Financial Performance Summary - For the first three quarters of 2024, the company achieved a total revenue of 394 million yuan, a year-on-year increase of 15.78%, and a net profit attributable to shareholders of 18 million yuan, up 1.60% year-on-year [2]. - In Q3 2024, the company reported revenue of 126 million yuan, a slight increase of 0.16% year-on-year but a decrease of 14.59% quarter-on-quarter [2]. - The gross profit margin for the first three quarters was 17.97%, an increase of 0.84 percentage points year-on-year [2]. Cash Flow and Expenses - The company reported positive operating cash flow for the first three quarters, with a net cash flow from operating activities of 19.64 million yuan, a significant increase of 313.29% year-on-year [3]. - The company has maintained stable expense ratios, with sales, management, and financial expense ratios at 0.70%, 6.85%, and 0.30%, respectively [3]. Business Development - The company is focusing on fine chemical products and green chemical solutions, with significant projects like the 30,000 tons/year tetrahydrofuran project entering production [4]. - The company is the only domestic manufacturer using oxidation technology for toluene oxidation products, achieving notable market shares in benzyl alcohol and benzaldehyde [4]. - The company has initiated trial production of a 1,000 tons/year ionic liquid catalyst project, which is expected to replace traditional mercury-containing catalysts [4]. Earnings Forecast - The forecast for net profit attributable to shareholders has been adjusted to 27 million yuan for 2024, 39 million yuan for 2025, and 48 million yuan for 2026, with corresponding P/E ratios of 59.15, 40.80, and 32.99 [5].

Investment Rating - The report downgrades the investment rating to "Outperform" due to significant price pressure on fine chemical products in 2024, while maintaining a long-term positive outlook on the economic benefits of new projects [6][8][11]. Core Views - The company reported Q3 results that fell short of expectations, with Q3 revenue of 126 million yuan, a year-on-year increase of 0.2% but a quarter-on-quarter decrease of 14.6%. The net profit attributable to the parent company was -1.58 million yuan, a year-on-year decline of 114.5% and a quarter-on-quarter decline of 109.4% [6][7]. - The decline in BDO prices has negatively impacted the performance of tetrahydrofuran, with average quarterly prices for BDO decreasing from 9331 yuan/ton in Q1 to 8104 yuan/ton in Q3. The average price for tetrahydrofuran also fell from 13,300 yuan/ton in Q1 to 12,300 yuan/ton in Q3 [6][7]. - The company is expected to face continued pressure in 2024 due to the high base from Q2's solution project revenue recognition and increasing pressure on key products [6][8]. Summary by Sections Financial Performance - For the first three quarters of 2024, the company achieved revenue of 394 million yuan, a year-on-year increase of 15.8%. The net profit attributable to the parent company was 17.74 million yuan, a year-on-year increase of 1.6% [6][7]. - The projected net profits for 2024, 2025, and 2026 are 23 million yuan, 24 million yuan, and 40 million yuan respectively, with corresponding PE ratios of 62, 59, and 35 times [6][8]. Market Conditions - The report highlights that the average operating rate for BDO has been declining, with Q3 showing an operating rate of 55.3%, down from 58.6% in Q1 [6][7]. - The price of benzyl alcohol saw a sharp decline in September, impacting the profit levels of the toluene oxidation series, which is a key product line for the company [6][7]. Future Outlook - The company is focusing on the ramp-up of new projects, particularly the 30,000-ton tetrahydrofuran capacity that has begun trial production. The economic benefits of this project are expected to significantly improve as BDO prices and operating rates recover [6][8]. - Long-term prospects are positive for the company's initiatives in PVC mercury-free and bio-based nylon 56, which align with green chemistry and bio-manufacturing principles [6][8].

证券代码：832471 证券简称：美邦科技 公告编号：2024-080 河北美邦工程科技股份有限公司 回购进展情况公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律 责任。 一、 回购方案基本情况 （一）审议及表决情况 河北美邦工程科技股份有限公司（以下简称"公司"）于 2023 年 11 月 28 日召开 第三届董事会第二十二次会议、第三届监事会第十七次会议，审议通过了《关于回购 股份方案的议案》。根据《公司法》《公司章程》等规定，公司回购本公司股份用于员 工持股计划或者股权激励的情形，经三分之二以上董事出席的董事会会议决议后，无 需再提交股东大会审议。 （二）回购用途及目的 基于对公司未来发展前景的信心和公司价值的认可，为建立、健全公司的长效激 励机制，吸引和留住优秀人才，充分调动管理层及员工的积极性，共同促进公司持续 稳定健康发展，在综合考虑公司发展前景、经营情况、财务状况及未来盈利能力等因 素的基础上，公司拟以自有资金回购公司股份，用于实施股权激励或员工持股计划。 （三） 回购方式 本次回购方式为竞价 ...

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 10 月 30 日 证券代码：832471 证券简称：美邦科技 公告编号：2024-077 河北美邦工程科技股份有限公司 第四届董事会第四次会议决议公告 2.会议召开地点：公司会议室 3.会议召开方式：现场及通讯 4.发出董事会会议通知的时间和方式：2024 年 10 月 25 日以邮件方式发出 5.会议主持人：董事长高文杲 6.会议列席人员：监事会成员、董事会秘书及公司高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召开、召集和表决程序符合《公司法》和《公司章程》有关法 律法规以及公司内部治理规则的规定，所作决议合法有效。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 二、议案审议情况 （一）审议通过《关于 2024 年第三季度报告的议案》 1.议案内容： 具体内容详见公司在北京证券交易所信息披露平台(www.bse.cn)上披露 的《 ...

证券代码：832471 证券简称：美邦科技 公告编号：2024-078 （一）会议召开情况 5.会议主持人：监事会主席马记 6.召开情况合法、合规、合章程性说明： 本次会议的召开、召集和表决程序符合《公司法》和《公司章程》有关法 律法规以及公司内部治理规则的规定，所作决议合法有效。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 河北美邦工程科技股份有限公司 第四届监事会第四次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 2.议案表决结果：同意 3 票；反对 0 票；弃权 0 票。 1.会议召开时间：2024 年 10 月 30 日 2.会议召开地点：公司会议室 3.会议召开方式：现场及通讯 4.发出监事会会议通知的时间和方式：2024 年 10 月 25 日以邮件方式发出 3.回避表决情况 本议案不涉及关联交易事项，无需回避表决。 本议案无需提交股东大会审议。 三、备查文件目录 （一）《河北美邦工程科技股份有限公司第四届监事会第四次会议 ...

Financial Performance - Operating revenue for the first nine months of 2024 was ¥394,229,848.87, representing a year-on-year growth of 15.78%[6] - Net profit attributable to shareholders for the first nine months of 2024 was ¥17,742,635.59, a slight increase of 1.60% from the previous year[6] - The total profit for the first nine months of 2024 was ¥15,511,925.92, compared to ¥18,136,862.27 in the same period of 2023, reflecting a decline of approximately 14.3%[28] - The net profit for the first nine months of 2024 was ¥13,151,274.43, compared to ¥16,153,778.52 in the same period of 2023, indicating a decrease of about 18.5%[28] - The operating profit for the first nine months of 2024 was ¥15,511,678.92, down from ¥18,620,552.70 in the same period of 2023, showing a decrease of about 16.9%[28] - The company recorded other comprehensive income after tax of -¥7,143.72, compared to ¥68,558.96 in the previous period, indicating a significant decline[28] - The total comprehensive income for the first nine months of 2024 was ¥13,144,130.71, down from ¥16,222,337.48 in the same period of 2023, reflecting a decrease of approximately 18.9%[29] Cash Flow - The net cash flow from operating activities improved significantly to ¥19,640,893.64, a 313.29% increase compared to the same period last year[6] - Operating cash flow for the first nine months of 2024 was CNY 19,640,893.64, a significant improvement from a negative cash flow of CNY -9,208,418.10 in the same period of 2023[31] - Total cash inflow from operating activities was CNY 336,084,740.88, slightly down from CNY 342,943,205.83 in the previous year[30] - Cash outflow for operating activities decreased to CNY 316,443,847.24 from CNY 352,151,623.93, showing a reduction of approximately 10.1%[30] - The company reported a net increase in cash and cash equivalents of CNY 10,754,193.58, contrasting with a decrease of CNY -13,846,533.71 in the prior year[31] - The ending balance of cash and cash equivalents as of September 2024 was CNY 99,794,825.13, compared to CNY 137,236,743.80 at the end of September 2023[31] Assets and Liabilities - Total assets as of September 30, 2024, reached ¥1,021,481,107.38, an increase of 7.08% compared to the end of the previous year[6] - The company's debt-to-asset ratio (consolidated) was 33.66%, up from 29.78% at the end of the previous year[6] - The total liabilities amounted to 343,841,839.14 CNY, while total equity reached 677,639,268.24 CNY, indicating a healthy equity position[22] - The company has pledged assets totaling 188,176,575.79 CNY, which represents 18.42% of total assets, to secure bank loans[18] - Current assets decreased slightly to 431,463,027.29 CNY from 437,777,843.53 CNY, indicating a decline of about 1.4%[20] - The company's fixed assets decreased to 251,988,872.90 CNY from 283,336,613.41 CNY, a reduction of approximately 11.0%[20] Shareholder Information - The total number of ordinary shares is 83,200,000, with 34.36% being unrestricted shares and 65.64% being restricted shares[10] - The top ten shareholders collectively hold 66.73% of the shares, with the largest shareholder owning 27.67%[11] - The company plans to repurchase shares at a price not exceeding ¥12.80 per share, with a total repurchase fund between ¥10,000,000 and ¥20,000,000, potentially acquiring 781,250 to 1,562,500 shares[15] - As of the reporting period, the company repurchased 1,231,000 shares, accounting for 1.48% of the total share capital, with a total expenditure of 11,217,892.58 CNY, which is 56.09% of the planned repurchase fund[16] Research and Development - Research and development expenses increased by 32.61% to ¥19,368,170.27, reflecting the company's commitment to new technology and product development[7] - Research and development expenses increased to ¥19,368,170.27 in 2024 from ¥14,605,859.97 in 2023, reflecting a growth of approximately 32.1%[26] - Research and development expenses increased to ¥2,130,290.19 from ¥1,837,040.69, representing a growth of approximately 15.9%[28] Investment Activities - The cash flow from investment activities showed a net outflow of ¥32,296,503.22, an increase of 67.41% due to investments in subsidiaries[8] - Total cash inflow from investment activities decreased to CNY 113,876,542.09 in 2024 from CNY 318,073,543.70 in 2023, indicating a decline of approximately 64.2%[31] - Cash outflow for investment activities was CNY 146,173,045.31, down from CNY 417,170,233.65 in the previous year, representing a reduction of about 65%[31] Other Financial Metrics - The company's financial expenses rose by 88.22% to ¥1,177,507.84, primarily due to increased interest expenses from bank loans[7] - The company reported a credit impairment loss of ¥4,762,830.02, a significant increase from a reversal of ¥2,728,214.77 in the previous year[28] - The company incurred sales expenses of ¥480,581.99, a decrease from ¥779,512.73 in the previous year, indicating a reduction of about 38.4%[28] - The company has no significant litigation or arbitration matters during the reporting period[13] - The company has not engaged in any external loans during the reporting period[13] - The company has not reported any significant related party transactions during the reporting period[13] - The company has not disclosed any major events or issues that would impact its operations negatively[13]

| 日期 | 代码 | 简称 | 成交数量（股） | 成交金额（万元） | 披露原因 | | --- | --- | --- | --- | --- | --- | | 2024-10- | | | | | 异常期间涨跌幅偏离值累计 | | 25 | 872374 | 云里物里 | 10711936.0 | 27300.04 | 达到64.84% | | 2024-10- | 430198 | 微创光电 | 58845916.0 | 79017.62 | 异常期间涨跌幅偏离值累计 | | 25 | | | | | 达到47.70% | | 2024-10- | 839167 | 同享科技 | 45570754.0 | 128413.2 | 异常期间涨跌幅偏离值累计 | | 25 | | | | | 达到42.74% | | 2024-10- 25 | 872374 | 云里物里 | 2384250 | 7965.78 | 当日收盘价涨幅达到30.00% | | 2024-10- 25 | 830779 | 武汉蓝电 | 3552531 | 11909.28 | 当日收盘价涨幅达到30.00% | | 2024 ...